Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -0.72 1.97 -1.63 13.83 10.76
Fund with Sales Charge (%) (POP) -0.72 1.97 -1.63 13.83 10.76
NASDAQ Biotechnology Index (%) -3.42 3.39 -1.17 13.82 11.02
S&P 500 Index (%) -6.98 5.10 6.72 10.53 6.69
Quarter EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -0.72 1.97 -1.63 13.83 10.76
Fund with Sales Charge (%) (POP) -0.72 1.97 -1.63 13.83 10.76
NASDAQ Biotechnology Index (%) -3.42 3.39 -1.17 13.82 11.02
S&P 500 Index (%) -6.98 5.10 6.72 10.53 6.69

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013
Fund without Sales Charge (%) (NAV) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
Fund with Sales Charge (%) (POP) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39

Cumulative Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.36 -0.72 6.03 -7.91 265.20 900.93
Fund with Sales Charge (%) (POP) -12.36 -0.72 6.03 -7.91 265.20 900.93
NASDAQ Biotechnology Index (%) -10.41 -3.42 10.52 -5.70 265.12 954.58
S&P 500 Index (%) -19.60 -6.98 16.11 38.47 172.10 330.05
Quarter EndAs of 03/31/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.36 -0.72 6.03 -7.91 265.20 900.93
Fund with Sales Charge (%) (POP) -12.36 -0.72 6.03 -7.91 265.20 900.93
NASDAQ Biotechnology Index (%) -10.41 -3.42 10.52 -5.70 265.12 954.58
S&P 500 Index (%) -19.60 -6.98 16.11 38.47 172.10 330.05

After-Tax Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -2.68 0.72 -3.06 12.39
Fund without Sales Charge (%) (NAV) After Shares Sold 1.33 1.48 -1.40 11.30
Fund with Sales Charge (%) (POP) Before Shares Sold -2.68 0.72 -3.06 12.39
Fund with Sales Charge (%) (POP) After Shares Sold 1.33 1.48 -1.40 11.30
Quarter EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -2.68 0.72 -3.06 12.39
Fund without Sales Charge (%) (NAV) After Shares Sold 1.33 1.48 -1.40 11.30
Fund with Sales Charge (%) (POP) Before Shares Sold -2.68 0.72 -3.06 12.39
Fund with Sales Charge (%) (POP) After Shares Sold 1.33 1.48 -1.40 11.30

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.72%
Net Expense Ratio [further-information] 0.65%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 03/31/2020 Updated Monthly, based on a 3-year period

Beta 1.05
Sharpe Ratio 0.01
Standard Deviation 22.79

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index